NCI’s Chabner Cautions Against 3-Hour Taxol Infusion, May Lower Response Rate
In Brief: Nobel Prize Awarded To Sharp, Roberts For Gene Splicing; ACS Fills Top Positions
Prostate Cancer Prevention Trial Begins At 222 U.S. Sites
Duke Physician, BM, Patients, Lobby For Reimbursement
Greenpeace Report Says Chemicals Causing Breast Cancers
DCT Board Okays Recompetition of Drug Discovery Groups
NCI Communications Office to contract Media Campaigns
Trending Stories
- Preparing to take care of each other in ways we never imagined
- 20 years of EGFR research: Ramalingam, Carbone, Politi, Jänne, Govindan reflect
- Federal judge blocks Trump administration’s move to limit indirect costs to 15% for NIH-funded institutions
The move could gut academic cancer research - From the chairs of ECOG-ACRIN: A perspective on indirect costs
- What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - On a new podcast, VCU’s Winn and City of Hope’s Carpten discuss the mission—and the future—of cancer centers
The Cancer Letter’s new podcast offers insight into cancer policy in a landscape of uncertainty